Plasma vitamins E and A and risk of bladder cancer: a case-control analysis

被引:22
作者
Liang, Dong [2 ]
Lin, Jie [1 ]
Grossman, H. Barton [3 ]
Ma, Jing [2 ]
Wei, Bo [2 ]
Dinney, Colin P. [3 ]
Wu, Xifeng [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Unit 1340, Houston, TX 77030 USA
[2] Texas So Univ, Dept Pharmaceut Sci, Houston, TX 77004 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
关键词
bladder cancer; vitamins A; E; plasma; case-control study;
D O I
10.1007/s10552-008-9165-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Current results on the association between serum micronutrients and bladder cancer risk have been inconsistent. We assessed plasma vitamin E (alpha-tocopherol, and gamma-tocopherol), vitamin A (retinol), and bladder cancer risk using data collected from a case-control study. Methods: Epidemiologic data were collected via in-person interview. Plasma concentrations of alpha-tocopherol, gamma-tocopherol, and retinol were determined by a high-performance liquid chromatography assay. Multivariate logistic regression analyses were used to estimate bladder cancer risk in association with plasma vitamins E and A. Results: 386 bladder cancer patients and 389 age-, gender-, and ethnicity-matched controls were included in the study. The mean plasma alpha-tocopherol and retinol were significantly lower in cases than in controls (alpha-tocopherol: 23.93 mu g/ml vs. 27.48 mu g/ml, P < 0.001; retinol: 1.41 mu g/ml vs. 1.53 mu g/ml, P < 0.001). There was a significant reduction in bladder cancer risk associated with increasing plasma alpha-tocopherol level (Adjusted OR: 0.91; 95% CI: 0.85-0.97). In quartile analysis, using subjects with the lowest alpha-tocopherol level as the reference group, the adjusted ORs and 95% CIs for the second, third, and fourth quartiles were 0.75 (0.50-1.14), 0.69 (0.46-1.05), and 0.50 (0.32-0.78), respectively (P for trend = 0.003). Increased retinol level was also associated with reduced risk with OR of 0.57 (95% CI: 0.40-0.81). The ORs and 95% CIs for the second, third, and fourth quartiles were 0.92 (0.61-1.39), 0.66 (0.43-1.01), and 0.62 (0.40-0.95), respectively, with significant dose-response trend (P for trend = 0.01). Finally, there were significant correlations between plasma levels and dietary intakes for the three micronutrients. Conclusion: Our results suggest potential protective effect of alpha-tocopherol and retinol on bladder cancer risk. Future large prospective studies are needed to confirm the findings.
引用
收藏
页码:981 / 992
页数:12
相关论文
共 35 条
[1]   The influence of cigarette smoking on circulating concentrations of antioxidant micronutrients [J].
Alberg, AJ .
TOXICOLOGY, 2002, 180 (02) :121-137
[2]   A DATA-BASED APPROACH TO DIET QUESTIONNAIRE DESIGN AND TESTING [J].
BLOCK, G ;
HARTMAN, AM ;
DRESSER, CM ;
CARROLL, MD ;
GANNON, J ;
GARDNER, L .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1986, 124 (03) :453-469
[3]  
BLOCK G, 1992, J AM DIET ASSOC, V92, P686
[4]   REVISION OF DIETARY ANALYSIS SOFTWARE FOR THE HEALTH HABITS AND HISTORY QUESTIONNAIRE [J].
BLOCK, G ;
COYLE, LM ;
HARTMAN, AM ;
SCOPPA, SM .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 139 (12) :1190-1196
[5]   The European perspective on vitamin E:: current knowledge and future research [J].
Brigelius-Flohé, R ;
Kelly, FJ ;
Salonen, JT ;
Neuzil, J ;
Zingg, JM ;
Azzi, A .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2002, 76 (04) :703-716
[6]  
*CDC, 2002, MMWR-MORBID MORTAL W, V51, P642
[7]   Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase γ-tocopherol in vivo after adjustment for dietary antioxidant intakes [J].
Dietrich, M ;
Block, G ;
Norkus, EP ;
Hudes, M ;
Traber, MG ;
Cross, CE ;
Packer, L .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2003, 77 (01) :160-166
[8]   A comparison of carotenoids, retinoids, and tocopherols in the serum and buccal mucosa of chronic cigarette smokers versus nonsmokers [J].
Gabriel, Helen E. ;
Liu, Zhenhua ;
Crott, Jimmy W. ;
Choi, Sang-Woon ;
Song, Byeng Chun ;
Mason, Joel B. ;
Johnson, Elizabeth J. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (05) :993-999
[9]  
HALLIWELL B, 1994, NUTR REV, V52, P253
[10]  
HELZLSOUER KJ, 1989, CANCER RES, V49, P6144